Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 56,670 | 63,543 | 64,223 | 68,033 | 59,366 |
| Cost of Goods | 33,842 | 43,575 | 36,611 | 36,319 | 34,464 |
| Gross Profit | 22,828 | 19,968 | 27,612 | 31,714 | 24,902 |
| Operating Expenses | 22,266 | 25,369 | 22,426 | 21,703 | 21,291 |
| Operating Income | 1,404 | -4,826 | 5,797 | 10,330 | 4,075 |
| Interest Expense | 191 | 54 | 281 | 305 | 384 |
| Other Income | 291 | -59 | 485 | -273 | 125 |
| Pre-tax Income | 1,504 | -4,939 | 6,001 | 9,752 | 3,816 |
| Income Tax | 611 | -1,485 | 2,111 | 2,857 | 1,327 |
| Net Income Continuous | 893 | -3,454 | 3,890 | 6,895 | 2,489 |
| Net Income | $893 | $-3,454 | $3,890 | $6,895 | $2,489 |
| EPS Basic Total Ops | 0.02 | -0.08 | 0.09 | 0.15 | 0.06 |
| EPS Basic Continuous Ops | 0.02 | -0.08 | 0.09 | 0.15 | 0.06 |
| EPS Diluted Total Ops | 0.02 | -0.07 | 0.08 | 0.15 | 0.05 |
| EPS Diluted Continuous Ops | 0.02 | -0.08 | 0.08 | 0.15 | 0.05 |
| EBITDA(a) | $5,225 | $-908 | $9,512 | $13,947 | $7,503 |